Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal (GI) tract is a primary site where the osmotic effects of sulfates manifest. Sulfate ions, when present in the intestinal lumen, are poorly absorbed, increasing the osmolality of intestinal contents. This draws water into the lumen, increasing stool fluidity and potentially causing diarrhea or a laxative effect. The osmotic-induced diarrhea ceases once these osmotically active substances are excreted from the GI tract. While not a specific molecular target like a receptor, the GI tract represents a functional target for osmotically active compounds.
Osmosis; Increased luminal osmolality leading to water influx into the gastrointestinal tract.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal Tract (Osmotic Effect via Sulfates) (GI Tract (Sulfate Osmosis)).